Fondaparinux Sodium Injection
Product Images NDC 55111-681

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Fondaparinux Sodium (NDC 55111-681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg2scarton (10mg2scarton)

Packaging label for Fondaparinux Sodium Injection 10 mg/0.8 mL by Dr. Reddy's Laboratories Limited. The product contains 2 single-dose prefilled syringes, each with 10 mg fondaparinux sodium in 0.8 mL isotonic solution. The injection is for subcutaneous use and features an active needle protection system. Storage instructions and barcode are also visible.*

FDA Label Image

25mg2scarton (25mg2scarton)

Packaging label for Fondaparinux Sodium Injection 2.5 mg/0.5 mL by Dr. Reddy's Laboratories Limited. The label indicates single-dose prefilled syringes with an active needle protection system for subcutaneous use. The box contains 2 syringes of 0.5 mL each, with storage instructions and dosing information provided on the label.*

FDA Label Image

5mg2scarton (5mg2scarton)

Fondaparinux Sodium Injection 5 mg/0.4 mL prefilled syringes packaging label by Dr. Reddy's Laboratories Limited. The label indicates it contains 2 single-dose, prefilled syringes, subcutaneous injection with an active needle protection system. Storage instructions and dosing information are also included on the label along with a barcode.*

FDA Label Image

75mg2scarton (75mg2scarton)

Packaging label for Fondaparinux Sodium Injection 7.5 mg/0.6 mL by Dr. Reddy's Laboratories Limited. The label indicates single-dose prefilled syringes with an active needle protection system for subcutaneous use, containing 7.5 mg fondaparinux sodium in 0.6 mL isotonic solution. The package contains 2 prefilled syringes and includes storage and usage information.*

FDA Label Image

Fig (Fig1)

An instructional illustration showing hands holding a syringe with arrows indicating the removal of the syringe cap, demonstrating a step in preparing a Fondaparinux Sodium injection for subcutaneous administration.*

FDA Label Image

Fig2 (Fig2)

An instructional image labeled Figure 2 showing a gloved hand administering a subcutaneous injection using a syringe and a vial, demonstrating the injection technique for a drug like Fondaparinux Sodium.*

FDA Label Image

Fig3 (Fig3)

An instructional photograph showing the subcutaneous injection of a drug into a patient's abdominal area, with a healthcare professional wearing gloves administering the injection using a syringe. The image is labeled as Figure 3.*

FDA Label Image

Fig4 (Fig4)

An instructional image showing a gloved hand holding a prefilled syringe of Fondaparinux Sodium injection, demonstrating the direction to push the syringe plunger with an arrow pointing forward. The syringe is for subcutaneous administration.*

FDA Label Image

Fig5 (Fig5)

An instructional illustration showing a hand inserting a vial into a device labeled 'SORINSPAD', guided by a downward arrow. The image likely demonstrates part of a preparation or loading process for a medical injection device.*

FDA Label Image

Instrucn2cond (Instruc2cond)

Text panel providing instructions for safely disposing of used Fondaparinux Sodium injection needles and syringes. It outlines FDA recommendations for disposal containers, including use of FDA-cleared sharps containers or suitable household containers, and advises following local regulations and FDA guidelines for sharps disposal. It emphasizes not throwing sharps in household trash or recycling.*

FDA Label Image

Instructions1 (Instructions1)

Instructions for self-administration of fondaparinux sodium injection are shown with labeled photos of the syringe parts: needle shield, plunger, finger-grip, and safety shield. Illustrations depict the syringe before and after use. Text instructions detail hand washing, patient positioning, injection site selection, cleaning with alcohol swab, and needle shield removal technique to avoid contamination.*

FDA Label Image

Instructions2 (Instructions2)

An instructional panel showing step-by-step photographic illustrations for subcutaneous injection technique. The images demonstrate pinching the skin to form a fold, inserting the needle at a 90-degree angle, injecting medication by pressing the syringe plunger, removing the syringe while keeping the plunger pressed, and activating the needle safety shield with an audible click.*

FDA Label Image

Structure (Structure)

Chemical structure diagram depicting the molecular arrangement of Fondaparinux Sodium, the active ingredient in the listed prescription drug injection by Dr. Reddy's Laboratories Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.